4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-012900
CEO and CFO bought 3,000 shares at $19.08 ($57,240)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-04-01 | Purchase | +3,000 | $19.08 | $57,240 | 5,350,777 | D |
| Open-market purchases · 3,000 sh · avg $19.08 · $57,240 | |||||||
Loading xslF345X05/ownership.xml…